Source: Web Search Revision Year: 2021 Publisher: Medochemie Ltd, 1-10 Constantinoupoleos Street, Limassol, 3011 Cyprus
Vezimed 5 mg, film-coated tablet.
Vezimed 10 mg, film-coated tablet.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Each 5 mg film-coated tablet is a yellow, round, biconvex film coated tablet with a diameter of 6mm. Each 10 mg film-coated tablet is a red, round, biconvex film coated tablet with a diameter of 8mm. |
Vezimed 5 mg, film-coated tablet: Each tablet contains 5 mg solifenacin succinate, corresponding to 3.8 mg solifenacin.
Vezimed 10 mg film-coated tablet: Each tablet contains 10 mg solifenacin succinate, corresponding to 7.5 mg solifenacin.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Solifenacin |
Solifenacin is a competitive, specific cholinergic-receptor antagonist. In vitro and in vivo pharmacological studies indicate that solifenacin is a competitive inhibitor of the muscarinic M3 subtype receptor. |
| List of Excipients |
|---|
|
Microcrystalline cellulose |
The tablets are packed in transparent PVC/PVDC-Aluminium blisters and cold forming aluminium/push through aluminium blisters.
The available pack sizes are: 10, 20, 30, 50, 60, 90, 100 film-coated tablets.
Not all pack sizes may be marketed.
Medochemie Ltd, 1-10 Constantinoupoleos Street, Limassol, 3011 Cyprus
5 mg: MA032/10201
10 mg: MA032/10202
10th January 2017 / 06th June 2021
| Drug | Countries | |
|---|---|---|
| VEZIMED | Cyprus, Malta, Romania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
